Canada Intraocular Lens (IOL) Market Outlook to 2022

GlobalDataが発行した調査報告書(GDMECC2080DB)
◆商品コード:GDMECC2080DB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年11月14日
◆ページ数:59
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,995 ⇒換算¥564,435見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD9,990 ⇒換算¥1,128,870見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD14,985 ⇒換算¥1,693,305見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Canada Intraocular Lens (IOL) Market Outlook to 2022
Summary

GlobalData’s new report, “Canada Intraocular Lens (IOL) Market Outlook to 2022″, provides key market data on the Canada Intraocular Lens (IOL) market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements – Foldable IOL and Polymethyl Methacrylate (PMMA) IOL.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Intraocular Lens (IOL) market segements – Foldable IOL and Polymethyl Methacrylate (PMMA) IOL.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the Canada Intraocular Lens (IOL) market.
- Key players covered include Alcon, Inc., Abbott Medical Optics, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Intraocular Lens (IOL) Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Intraocular Lens (IOL) Market, Canada 7
3.1 Intraocular Lens (IOL) Market, Canada, Revenue ($m), 2008-2015 7
3.2 Intraocular Lens (IOL) Market, Canada, Revenue ($m), 2015-2022 9
3.2.1 Foldable IOL Market, Canada, Revenue ($m), by Segment, 2008-2015 11
3.2.2 Foldable IOL Market, Canada, Revenue ($m), by Segment, 2015-2022 13
3.3 Intraocular Lens (IOL) Market, Canada, Volume (Units), 2008-2015 15
3.4 Intraocular Lens (IOL) Market, Canada, Volume (Units), 2015-2022 17
3.4.1 Foldable IOL Market, Canada, Volume (Units), by Segment, 2008-2015 19
3.4.2 Foldable IOL Market, Canada, Volume (Units), by Segment, 2015-2022 21
3.5 Intraocular Lens (IOL) Market, Canada, Average Price ($), 2008-2022 23
3.6 Intraocular Lens (IOL) Market, Canada, Distribution Share by Revenue ($m), 2014-2015 24
3.7 Intraocular Lens (IOL) Market, Canada, Company Share by Revenue ($m), 2015 25
4 Overview of Key Companies in Canada, Intraocular Lens (IOL) Market 27
4.1 Abbott Medical Optics, Inc. 27
4.1.1 Company Overview 27
4.2 Bausch & Lomb Incorporated 27
4.2.1 Company Overview 27
4.3 Hoya Corporation 27
4.3.1 Company Overview 27
4.4 Carl Zeiss AG 28
4.4.1 Company Overview 28
4.5 Alcon, Inc. 28
4.5.1 Company Overview 28
5 Intraocular Lens (IOL) Market Pipeline Products 29
6 Financial Deals Landscape 30
6.1 Private Equity 30
6.1.1 Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management 30
7 Recent Developments 31
7.1 Corporate Communications 31
7.1.1 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer 31
7.1.2 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer 31
7.1.3 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team 32
7.1.4 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors 34
7.1.5 Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director 35
7.1.6 May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller 35
7.1.7 May 03, 2016: Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals 36
7.1.8 Apr 29, 2016: Valeant Announces Nominees For Election To Board Of Directors 37
7.1.9 Apr 25, 2016: Valeant Names Joseph C. Papa To Be Chairman And Chief Executive Officer Of Valeant Pharmaceuticals 38
7.1.10 Mar 21, 2016: Valeant Announces CEO Succession Plan And Changes To Board Of Directors 39
7.1.11 Mar 09, 2016: Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board 40
7.1.12 Mar 02, 2016: Valeant Pharmaceuticals Announces Management Change 41
7.1.13 Feb 28, 2016: Valeant Pharmaceuticals Announces Management And Business Update 41
7.2 Financial Announcements 42
7.2.1 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results 42
7.2.2 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results 46
7.2.3 Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results 47
7.2.4 Mar 15, 2016: Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information 49
7.3 Legal And Regulatory 50
7.3.1 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation 50
7.3.2 Mar 09, 2016: Valeant And R&O Pharmacy End Litigation 50
7.4 Other Significant Developments 50
7.4.1 Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations 50
7.4.2 May 16, 2016: Valeant Pharmaceuticals Provides Update on Regulatory Matters 51
7.4.3 Apr 13, 2016: Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters 51
7.4.4 Mar 21, 2016: Valeant Provides Accounting And Financial Reporting Update 52
8 Appendix 55
8.1 Research Methodology 56
8.1.1 Coverage 56
8.1.2 Secondary Research 56
8.1.3 Primary Research 57
8.1.4 Company Share Analysis 57
8.1.5 Distribution Share Analysis 57
8.1.6 Benchmarking 58
8.2 GlobalData Consulting 58
8.3 Contact Us 58
8.4 Disclaimer 59

1.1 List of Tables
Table 1: Intraocular Lens (IOL) Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 8
Table 2: Intraocular Lens (IOL) Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Table 3: Foldable IOL Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 12
Table 4: Foldable IOL Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 14
Table 5: Intraocular Lens (IOL) Market, Canada, Volume (Units), Historic, 2008-2015 16
Table 6: Intraocular Lens (IOL) Market, Canada, Volume (Units), Forecast, 2015-2022 18
Table 7: Foldable IOL Market, Canada, Volume (Units), Historic, 2008-2015 20
Table 8: Foldable IOL Market, Canada, Volume (Units), Forecast, 2015-2022 22
Table 9: Intraocular Lens (IOL) Market, Canada, Average Price ($) Historic, 2008-2022 23
Table 10: Intraocular Lens (IOL) Market, Canada, Average Price ($), Forecast, 2015-2022 23
Table 11: Intraocular Lens (IOL) Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015 24
Table 12: Intraocular Lens (IOL) Market, Canada, Company Share by Revenue ($m), USD Constant, 2015 26
Table 13: Intraocular Lens (IOL) Market Pipeline Products 29
Table 14: Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management 30

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Canada Intraocular Lens (IOL) Market Outlook to 2022]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆